{"title":"NM_007294.3:c.446A\u003eC AND Breast-ovarian cancer, familial 1","submission_id":"500037.2012-07-24","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000053775","review_status":"no assertion criteria provided","variation_archive_id":"VCV000037594","date_created":"2012-11-07","version":"3","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2008-09-04","assertion_type":"variation to disease","internal_id":"89390","clinical_assertion_observation_ids":["SCV000053775.0"],"id":"SCV000053775","local_key":"SCRP_var_219","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000031175","record_status":"current","submitter_id":"500037"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Insufficient or conflicting evidence\"}"],"clinical_assertion_trait_set_id":"SCV000274232","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-05-27","version":"2","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-24","assertion_type":"variation to disease","internal_id":"510686","clinical_assertion_observation_ids":["SCV000274232.0"],"id":"SCV000274232","local_key":"a31329","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000219296","record_status":"current","submitter_id":"61756"}
{"submission_id":"500105.2018-11-14","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000895101","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Abbrev\":\"ACMG, 2015\",\"@Type\":\"practice guideline\",\"ID\":[{\"$\":\"25741868\",\"@Source\":\"PubMed\"},{\"$\":\"10.1038/gim.2015.30\",\"@Source\":\"DOI\"}]}}","date_created":"2019-03-28","version":"1","submission_names":["SUB4786732"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-10-31","assertion_type":"variation to disease","internal_id":"1751540","clinical_assertion_observation_ids":["SCV000895101.0"],"id":"SCV000895101","local_key":":Chr.17_41251893_41251893_T_G|OMIM:114480;604370;614320;617883","interpretation_description":"Uncertain significance","variation_id":"37594","record_status":"current","submitter_id":"500105"}
{"submission_id":"505849.2018-11-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000910906","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-05-17","version":"1","trait_set_id":"13598","submission_names":["SUB4721021"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-04-19","assertion_type":"variation to disease","internal_id":"1778861","clinical_assertion_observation_ids":["SCV000910906.0"],"id":"SCV000910906","local_key":"Db4KrQBSZeoE7-orUyypkaRSy9Lm52xvIWbvYpjplzM|MedGen:C0027672","interpretation_description":"Likely benign","variation_id":"37594","rcv_accession_id":"RCV000219296","record_status":"current","submitter_id":"505849"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces glutamic acid with alanine at codon 149 of the BRCA1 protein (p.Glu149Ala). The glutamic acid residue is moderately conserved and there is a moderate physicochemical difference between glutamic acid and alanine. This variant is present in population databases (rs397507233, ExAC 0.07%). This variant has been reported in individuals affected with breast cancer (PMID: 22116506, 27257965) and stomach cancer (PMID: 26689913). ClinVar contains an entry for this variant (Variation ID: 37594). Experimental studies have shown that this missense change does not impact BRCA1 homology-directed repair activity (PMID: 26689913). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.\"}"],"clinical_assertion_trait_set_id":"SCV000549301","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26689913\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22116506\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-04-13","version":"5","trait_set_id":"7920","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-19","assertion_type":"variation to disease","internal_id":"1062197","clinical_assertion_observation_ids":["SCV000549301.0"],"id":"SCV000549301","local_key":"676082|MedGen:C0677776","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000458634","record_status":"current","submitter_id":"500031"}
{"submission_id":"26957.2019-01-29","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted BRCA1 c.446A\u003eC at the cDNA level, p.Glu149Ala (E149A) at the protein level, and results in the change of a Glutamic Acid to an Alanine (GAA\u003eGCA). Using alternate nomenclature, this variant would be defined as BRCA1 565A\u003eC. This variant was observed in several individuals with breast cancer and in one individual with gastric cancer (Zhang 2012, Lu 2015, Zhong 2016, Wei 2018). Functional analysis of this variant showed no significant difference as compared to wild type in a homologous directed repair assay (Lu 2015). BRCA1 Glu149Ala was observed at an allele frequency of 0.06% (12/18870) in individuals of East Asian ancestry in large population cohorts (Lek 2016). This variant is located within a region that binds BRD7 (Harte 2010). Protein-based in silico analysis, which includes protein predictors and evolutionary conservation, predicts that this variant is probably damaging to protein structure and function, and splicing models are uninformative in their assessment as to whether or not the variant is damaging. Based on currently available evidence, it is unclear whether BRCA1 Glu149Ala is a pathogenic or benign variant. We consider it to be a variant of uncertain significance.\"}"],"clinical_assertion_trait_set_id":"SCV000570422","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2017-04-24","version":"5","trait_set_id":"9460","submission_names":["SUB5098196"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-09-25","assertion_type":"variation to disease","internal_id":"1105529","clinical_assertion_observation_ids":["SCV000570422.0"],"id":"SCV000570422","local_key":"GDX:1080047|Not Provided","interpretation_description":"Uncertain significance","variation_id":"37594","rcv_accession_id":"RCV000479398","record_status":"current","submitter_id":"26957"}
{"submission_id":"505720.2016-02-27","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000265873","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000037594","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}],\"Interpretation\":{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"27257965\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-03-15","version":"1","submission_names":["Chinese507BC_BRCA"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-01","assertion_type":"variation to disease","internal_id":"498108","clinical_assertion_observation_ids":["SCV000265873.0"],"id":"SCV000265873","local_key":"NM_007294.3:c.446A\u003eC|MedGen:CN221572","interpretation_description":"Uncertain significance","variation_id":"37594","record_status":"current","submitter_id":"505720"}
{"submission_id":"506039.2018-11-26","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000883121","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2019-02-15","version":"1","trait_set_id":"6265","submission_names":["SUB4842992"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-11-21","assertion_type":"variation to disease","internal_id":"1729239","clinical_assertion_observation_ids":["SCV000883121.0"],"id":"SCV000883121","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"506039"}
{"submission_id":"25969.2018-10-10","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The APC c.3920T\u003eA; p.Ile1307Lys variant has been reported extensively in the literature. One recent meta-analysis of 30 published population studies, all of which examined the association between p.Ile1307Lys and colorectal neoplasia, colorectal adenoma, and/or colorectal cancer, concluded that this variant confers a two-fold increased risk of developing a colorectal neoplasia to persons of Ashkenazi Jewish ancestry (Liang 2013 and references therein). However, the c.3920T\u003eA;p.Ile1307Lys variant is observed in the general population at an overall frequency of 0.18% (506/276756 alleles, 6 homozygotes) in the Genome Aggregation Database. Due to the high frequency in the general population, this variant is considered likely benign. REFERENCES Liang et al. APC polymorphisms and the risk of colorectal neoplasia: a HuGE review and meta-analysis. Am J Epidemiol. 2013;177(11):1169-1179.\"}"],"clinical_assertion_trait_set_id":"SCV000602533","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ARUP Molecular Germline Variant Investigation Process\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nr7Bh7s8/ARUP_MolecularGermlineVariantInvestigationProcess.pdf\"}}}}","date_created":"2017-09-27","version":"2","trait_set_id":"9460","submission_names":["SUB4618058"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-06-20","assertion_type":"variation to disease","internal_id":"1166229","clinical_assertion_observation_ids":["SCV000602533.0"],"id":"SCV000602533","local_key":"11931|Not Provided","interpretation_description":"Likely benign","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"25969"}
{"submission_id":"500110.2020-03-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000600091","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29478780\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16875934\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29506128\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30487145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"12533824\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135136\",\"@Source\":\"PubMed\"}}]}}","date_created":"2017-09-27","version":"2","trait_set_id":"9460","submission_names":["SUB6975398"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-08-04","assertion_type":"variation to disease","internal_id":"1163765","clinical_assertion_observation_ids":["SCV000600091.0"],"id":"SCV000600091","local_key":"2564206|not provided","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"500110"}
{"submission_id":"505698.2017-10-05","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000610138","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-11-02","version":"1","trait_set_id":"9460","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-07-27","assertion_type":"variation to disease","internal_id":"1190191","clinical_assertion_observation_ids":["SCV000610138.0"],"id":"SCV000610138","local_key":"19388615","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"505698"}
{"submission_id":"26957.2018-09-07","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This variant is denoted APC c.3920T\u003eA at the DNA level and p.Ile1307Lys (I1307K) at the protein level, replacing an Isoleucine with a Lysine. APC Ile1307Lys is a common variant, observed at an allele frequency of 3.7% (371/10,138) in individuals of Ashkenazi Jewish ancestry in large population cohorts (Lek 2016) and in up to 11% of individuals in Ashkenazi Jewish cohorts in the literature (Liang 2013, Boursi 2013). A meta-analysis of epidemiologic studies of APC polymorphisms suggests that individuals of Ashkenazi Jewish ancestry who carry this variant have a 2-fold increased risk of colorectal cancer (Liang 2013). However, studies of this variant in other populations did not report an increased risk of colorectal cancer (Liang 2013); therefore, the clinical significance in individuals without Jewish ancestry is not clear at this time. In sum, we consider APC Ile1307Lys to be a risk allele. The National Comprehensive Cancer Network has management guidelines for individuals carrying the APC Ile1307Lys risk allele (NCCN).\"}"],"clinical_assertion_trait_set_id":"SCV000148996","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDX Variant Classification(06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2014-05-13","version":"4","trait_set_id":"9460","submission_names":["SUB4498316"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-05-08","assertion_type":"variation to disease","internal_id":"269650","clinical_assertion_observation_ids":["SCV000148996.0"],"id":"SCV000148996","local_key":"GDX:3786|Not Provided","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"26957"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change replaces isoleucine with lysine at codon 1307 of the APC protein (p.Ile1307Lys). The isoleucine residue is weakly conserved and there is a moderate physicochemical difference between isoleucine and lysine. This variant is present in population databases (rs1801155, ExAC 0.3%). This variant is found in ~10% of Ashkenazi Jewish individuals and ~3% of Sephardic Jewish individuals (PMID: 23896379). Other studies have reported a 6-7% frequency in Ashkenazi individuals (PMID: 9288102). This variant is found in ~28% of Ashkenazi Jewish individuals with familial colorectal cancer (PMID: 9288102). ClinVar contains an entry for this variant (Variation ID: 822). In a large meta-analysis involving ~10,000 cases and controls (PMID: 23576677), Ashkenazi Jewish individuals who carried the I1307K change had a significantly increased risk of colorectal cancer (OR=2.17, 95% CI=1.65-2.86). By contrast, the I1307K change did not appear to confer any additional risk of colorectal cancer in non-Ashkenazi Jewish individuals (OR=1.36, 95% CI=0.59-3.13). This DNA substitution converts an AAATAAAA sequence element into an extended tract of eight adenosine nucleotides (A8). The A8 mononucleotide tract created by this change has been shown to confer an increased propensity for somatic truncating mutations on this allele (PMID: 9751605). In summary, this is a frequently observed variant that is associated with a 2-fold increased risk of colorectal cancer in the Ashkenazi Jewish population. An increased risk of colorectal cancer in individuals who are not of Ashkenazi Jewish ancestry has not been established.\"}"],"clinical_assertion_trait_set_id":"SCV000153895","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-06-03","version":"9","trait_set_id":"6265","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-01-14","assertion_type":"variation to disease","internal_id":"279290","clinical_assertion_observation_ids":["SCV000153895.0"],"id":"SCV000153895","local_key":"7840|MedGen:C2713442","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500031"}
{"submission_id":"504914.2014-05-29","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000084184","review_status":"no assertion provided","variation_archive_id":"VCV000000822","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},\"Comment\":{\"$\":\"Please see associated publication for description of ethnicities\"}}","date_created":"2014-06-09","version":"1","trait_set_id":"9590","submission_names":["Cancer_genes_01"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2013-09-19","assertion_type":"variation to disease","internal_id":"281153","clinical_assertion_observation_ids":["SCV000084184.0","SCV000084184.1","SCV000084184.2","SCV000084184.3","SCV000084184.4","SCV000084184.5","SCV000084184.6"],"id":"SCV000084184","local_key":"MedGen:CN169374","interpretation_description":"not provided","variation_id":"822","rcv_accession_id":"RCV000120049","record_status":"current","submitter_id":"504914"}
{"submission_id":"165021.2016-01-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000297021","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"DGD Variant Analysis Guidelines\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"DGD_Variant_Analysis_Guidelines.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/q5qzurm4/dgd_variant_analysis_guidelines.docx\"}}},\"StudyDescription\":{\"$\":\"Clinical exome data\"}}","date_created":"2016-07-29","version":"2","trait_set_id":"8942","submission_names":["exome2015-12-22"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-24","assertion_type":"variation to disease","internal_id":"574598","clinical_assertion_observation_ids":["SCV000297021.0"],"id":"SCV000297021","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0032580","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000238802","record_status":"current","submitter_id":"165021"}
{"submission_id":"505870.2019-07-12","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV001154466","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Praxis fuer Humangenetik Tuebingen - Variant Classification Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/TbQpmFtg/PHGTv1.pdf\"}}}}","date_created":"2020-01-31","version":"1","trait_set_id":"9460","submission_names":["2019-07"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-05-01","assertion_type":"variation to disease","internal_id":"2272833","clinical_assertion_observation_ids":["SCV001154466.0"],"id":"SCV001154466","local_key":":Chr.5_112175211_112175211_T_A|MedGen:CN517202","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"505870"}
{"submission_id":"239772.2018-01-29","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000805404","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-09-12","version":"1","trait_set_id":"9460","submission_names":["SUB3589995"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-01-06","assertion_type":"variation to disease","internal_id":"1570355","clinical_assertion_observation_ids":["SCV000805404.0"],"id":"SCV000805404","local_key":"NM_000038.5:c.3920T\u003eA|not provided","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"239772"}
{"submission_id":"320494.2017-06-22","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"I1307K is associated with a 10-20% lifetime risk of developing colon cancer in individuals of Ashkenazi Jewish ancestry and is not known to cause classic or attenuated FAP.\"}"],"clinical_assertion_trait_set_id":"SCV000677724","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_%25282015%2529_v1.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24310308\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17854661\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24728327\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15712637\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24599579\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11001924\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-01-04","version":"1","trait_set_id":"6265","submission_names":["SUB2805501"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-09-27","assertion_type":"variation to disease","internal_id":"1328882","clinical_assertion_observation_ids":["SCV000677724.0"],"id":"SCV000677724","local_key":"76464|OMIM:175100","interpretation_description":"Likely pathogenic","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"320494"}
{"submission_id":"1024.2018-07-17","submitted_assembly":"GRCh38","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000807826","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-09-20","version":"1","trait_set_id":"35108","submission_names":["SUB4304907"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-06-01","assertion_type":"variation to disease","internal_id":"1575248","clinical_assertion_observation_ids":["SCV000807826.0"],"id":"SCV000807826","local_key":"APC-B1|MedGen:CN240755","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000680453","record_status":"current","submitter_id":"1024"}
{"submission_id":"500035.2018-11-11","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000838110","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","date_created":"2018-10-05","version":"2","trait_set_id":"6265","submission_names":["MENDELICS_CLINVAR_015"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-07-02","assertion_type":"variation to disease","internal_id":"1610680","clinical_assertion_observation_ids":["SCV000838110.0"],"id":"SCV000838110","local_key":"NC_000005.9:g.112175211T\u003eA|MedGen:C2713442","interpretation_description":"Likely pathogenic","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500035"}
{"submission_id":"505504.2018-08-08","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000821694","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-05","version":"1","trait_set_id":"13598","submission_names":["SUB4381212"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-08-01","assertion_type":"variation to disease","internal_id":"1609757","clinical_assertion_observation_ids":["SCV000821694.0"],"id":"SCV000821694","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:C0027672","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"505504"}
{"title":"APC, ILE1307LYS_BREAST CANCER, SUSCEPTIBILITY TO","submission_id":"3.2010-12-30","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000021015","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2011-01-25","version":"3","trait_set_id":"216","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2003-12-01","assertion_type":"variation to included disease","internal_id":"21015","clinical_assertion_observation_ids":["SCV000021015.0"],"id":"SCV000021015","local_key":"611731.0029_BREAST CANCER, SUSCEPTIBILITY TO","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000000865","record_status":"current","submitter_id":"3"}
{"title":"APC, ILE1307LYS_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","submission_id":"3.2014-02-19","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000021014","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2011-01-25","version":"3","trait_set_id":"215","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-04-01","assertion_type":"variation to disease","internal_id":"21014","clinical_assertion_observation_ids":["SCV000021014.0"],"id":"SCV000021014","local_key":"611731.0029_FAMILIAL ADENOMATOUS POLYPOSIS 1, SUSCEPTIBILITY TO","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000000864","record_status":"current","submitter_id":"3"}
{"submission_id":"500199.2018-06-14","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The c.3920T\u003eA (p.Ile1307Lys) variant in the APC gene has been reported as a common risk allele associated with familial colorectal cancer in the Ashkenazi Jewish population [PMID 18770064, 24416237]. The c.3920T\u003eA variant has been reported to result in an adenine replacing a thymine and creating an oligo-adenine (A8) tract that appears to be inherently prone to further somatic mis-pairing and slippage during DNA replication, thereby creating a frameshift change [PMID 9288102, 18770064 and 244162370]. However, this variant has also been reported at a high frequency, present in 6% of Ashkenazi Jews and about 28% of Ashkenazim with a family history of colorectal cancer [PMID: 9288102]. Isoleucine at amino acid position 1307 of the APC protein is weakly conserved during evolution. While not validated for clinical use, the SIFT and PolyPhen-2 algorithms predict this variant to be benign. Ashkenazi Jews who carry the p.Ile1307Lys variant are at increased risk for colorectal neoplasia: the risk for colorectal neoplasia in heterozygous Ashkenazi Jewish individuals was estimated to be between 1.7 to 2.17 compared to non carrier individuals [PMID 12173321, 23576677, 23896379]. This variant is classified as as a risk allele with an increased risk for colorectal neoplasia in the Ashkenazi Jewish population. However the risk in non Jewish populations has not been determined.\"}"],"clinical_assertion_trait_set_id":"SCV000839876","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-10-11","version":"1","trait_set_id":"6265","submission_names":["SUB4151980"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-06-02","assertion_type":"variation to disease","internal_id":"1637429","clinical_assertion_observation_ids":["SCV000839876.0"],"id":"SCV000839876","local_key":"NM_000038.5:c.3920T\u003eA|OMIM:175100","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500199"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Significant disease association in appropriately sized case-control study(ies);Detected in individual satisfying established diagnostic critera for classic disease without a clear mutation;Other strong data supporting pathogenic classification\"}"],"clinical_assertion_trait_set_id":"SCV000183892","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"26314409\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27146957\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16228836\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10938175\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-08-01","version":"7","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-02-28","assertion_type":"variation to disease","internal_id":"302407","clinical_assertion_observation_ids":["SCV000183892.0"],"id":"SCV000183892","local_key":"a4793","interpretation_description":"Pathogenic","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"61756"}
{"submission_id":"505849.2018-11-06","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000686956","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-02-16","version":"2","trait_set_id":"13598","submission_names":["SUB4721021"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-21","assertion_type":"variation to disease","internal_id":"1344252","clinical_assertion_observation_ids":["SCV000686956.0"],"id":"SCV000686956","local_key":"Db4KrQBSZeoE7-orUyypkal4dklV7Tc_lQTp9W4PGUo|MedGen:C0027672","interpretation_description":"Likely pathogenic","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"505849"}
{"submission_id":"1160.2012-07-15","interpretation_comments":["{\"text\":\"Converted during submission to Uncertain significance.\"}"],"clinical_assertion_trait_set_id":"SCV000043125","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","content":"{\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"22703879\",\"@Source\":\"PubMed\"}},\"StudyName\":{\"$\":\"ClinSeq\"}}","date_created":"2013-03-26","version":"1","trait_set_id":"9460","submission_names":["ClinSeq_cancer"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2012-07-13","assertion_type":"variation to disease","internal_id":"98286","clinical_assertion_observation_ids":["SCV000043125.0"],"id":"SCV000043125","local_key":"NM_000038.4:c.3920T\u003eA|not provided","interpretation_description":"variant of unknown significance","variation_id":"822","rcv_accession_id":"RCV000034388","record_status":"current","submitter_id":"1160"}
{"submission_id":"506273.2017-11-15","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000693480","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2018-03-01","version":"1","trait_set_id":"13598","submission_names":["SUB3222006"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-11-10","assertion_type":"variation to disease","internal_id":"1359177","clinical_assertion_observation_ids":["SCV000693480.0"],"id":"SCV000693480","local_key":"CCDS4107.1:c.3920T\u003eA|Hereditary cancer-predisposing syndrome","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000115087","record_status":"current","submitter_id":"506273"}
{"submission_id":"506211.2018-10-29","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000853088","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11159880\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-11-21","version":"1","trait_set_id":"1735","submission_names":["SUB4705375"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-01-01","assertion_type":"variation to disease","internal_id":"1663716","clinical_assertion_observation_ids":["SCV000853088.0"],"id":"SCV000853088","local_key":"NM_001127510.2:c.3920T\u003eA|MedGen:C0699790","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000722046","record_status":"current","submitter_id":"506211"}
{"submission_id":"500026.2019-09-24","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: APC c.3920T\u003eA (p.Ile1307Lys) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.002 in 251040 control chromosomes in the gnomAD database (exomes dataset), predominantly found within the Ashkenazi Jewish subpopulation at a frequency of 0.036, including 7 homozygotes. The observed variant frequency within Ashkenazi Jewish control individuals in the gnomAD database is approximately 500 fold of the estimated maximal expected allele frequency for a pathogenic variant in APC causing Familial Adenomatous Polyposis (FAP) phenotype (7.1e-05), strongly suggesting that the variant is a benign polymorphism found primarily in populations of Ashkenazi Jewish origin. The variant, c.3920T\u003eA, has been reported in the literature in multiple individuals affected with colorectal cancer (CRC) and other tumor phenotypes, however in some of these cases it was also reported to co-occur with other pathogenic variants (Yurgelun_2017 and Simbolo_2015). Multiple case-control studies (Abdel-Malak_2016, Drucker_2000, Fidder_2005, Gryfe_1998, Laken_1997, Leshno_2016, and Shtoyerman-Chen_2001), demonstrated that this variant is associated with a moderately increased risk for CRC in Ashkenazi Jewish population. A large meta-analysis concluded that the variant increases the risk about two-fold for CRC in individuals of Ashkenazi Jewish ancestry (OR=2.17, 95% CI=1.65-2.86), however it does not appear to confer an additional risk for CRC in non-Ashkenazi cases (Liang_2013). A recent case-control study involving a large Israeli cohort indicated that this variant might be also associated with a significantly higher risk for non-CRC cancers, with the APC I1307K variant being proposed as a reliable marker for overall cancer risk (OR=2.53) (Leshno_2016). The A8 mononucleotide tract created by this germline change has been shown to confer an increased propensity for generating somatic frameshift mutations on this allele, leading to a loss of function of APC that constitutes an important somatic event in tumor initiation (Gryfe_1998; Laken_1997). 19 other submitters have provided clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Multiple laboratories reported the variant with conflicting assessments, with 7 reporting it as a risk factor. Taken together, this polymorphic variant is associated with a modestly increased risk for CRC in the Ashkenazi Jewish population, but is not associated with FAP or AFAP. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000694042","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"18343606\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9751605\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26300997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26394139\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26421687\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24416237\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27153395\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27978560\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14633595\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28135145\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28050010\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25604157\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10679643\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"15929773\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11207040\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28749474\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30152102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30426508\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"26187149\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29961768\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","version":"2","trait_set_id":"9590","submission_names":["SUB6341163"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-08-27","assertion_type":"variation to disease","internal_id":"1360394","clinical_assertion_observation_ids":["SCV000694042.0"],"id":"SCV000694042","local_key":"NM_000038.5:c.3920T\u003eA|MedGen:CN169374","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000120049","record_status":"current","submitter_id":"500026"}
{"submission_id":"506834.2016-03-03","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Low penetrance mutation that is associated with a small increase in risk of colon cancer and with an increased risk of colon polyps (Boursi 2013)\"}"],"clinical_assertion_trait_set_id":"SCV000266006","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Shirts et al. (Genet Med 2016)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26845104\",\"@Source\":\"PubMed\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"}}","date_created":"2016-03-19","version":"1","trait_set_id":"1570","submission_names":["GIM_BROCA"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-20","assertion_type":"variation to disease","internal_id":"498299","clinical_assertion_observation_ids":["SCV000266006.0","SCV000266006.1","SCV000266006.2","SCV000266006.3","SCV000266006.4","SCV000266006.5","SCV000266006.6","SCV000266006.7","SCV000266006.8"],"id":"SCV000266006","local_key":"c.3920T\u003eA","interpretation_description":"risk factor","variation_id":"822","rcv_accession_id":"RCV000210085","record_status":"current","submitter_id":"506834"}
{"submission_id":"506152.2017-04-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000591159","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000000822","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"9731533\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9973276\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9724771\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23896379\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"9288102\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16140997\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23576677\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"19047896\",\"@Source\":\"PubMed\"}}]},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-25","version":"1","trait_set_id":"9590","submission_names":["SHS20170111"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-08-15","assertion_type":"variation to disease","internal_id":"1147603","clinical_assertion_observation_ids":["SCV000591159.0"],"id":"SCV000591159","local_key":"NM_000038.5:c.3920T\u003eA|not specified","interpretation_description":"Uncertain significance","variation_id":"822","rcv_accession_id":"RCV000120049","record_status":"current","submitter_id":"506152"}
{"title":"NM_000038.3:c.3920T\u003eA and APC-Associated Polyposis Conditions","submission_id":"500062.2013-01-08","interpretation_comments":["{\"text\":\"Converted during submission to Pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000040392","review_status":"no assertion criteria provided","variation_archive_id":"VCV000000822","date_created":"2011-05-06","version":"1","trait_set_id":"6265","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2011-10-27","assertion_type":"variation to disease","internal_id":"40392","clinical_assertion_observation_ids":["SCV000040392.0"],"id":"SCV000040392","local_key":"NM_000038.3:c.3920T\u003eA_NBK1345","interpretation_description":"pathologic","variation_id":"822","rcv_accession_id":"RCV000020088","record_status":"current","submitter_id":"500062"}
{"submission_id":"500031.2019-03-28","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This sequence change creates a premature translational stop signal (p.Asn1355Lysfs*10) in the BRCA1 gene. It is expected to result in an absent or disrupted protein product. This variant is present in population databases (rs80357508, ExAC 0.006%). This variant has been reported in multiple individuals and families affected with breast and ovarian cancer (PMID: 14757871, 8571953, 11802209, 21559243). This variant is also known as 4184del4 in the literature. ClinVar contains an entry for this variant (Variation ID: 17674). Loss-of-function variants in BRCA1 are known to be pathogenic (PMID: 20104584). For these reasons, this variant has been classified as Pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000076444","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Invitae Variant Classification Sherloc (09022015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"28492532\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}}]}}","date_created":"2013-07-02","version":"11","trait_set_id":"7920","submission_names":["SUB5371970"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-01-09","assertion_type":"variation to disease","internal_id":"124374","clinical_assertion_observation_ids":["SCV000076444.0"],"id":"SCV000076444","local_key":"306942|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"500031"}
{"submission_id":"504196.2014-03-28","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000144954","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","date_created":"2014-03-30","version":"2","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2002-05-29","assertion_type":"variation to disease","internal_id":"261852","clinical_assertion_observation_ids":["SCV000144954.0","SCV000144954.1","SCV000144954.2","SCV000144954.3","SCV000144954.4","SCV000144954.5","SCV000144954.6","SCV000144954.7","SCV000144954.8","SCV000144954.9","SCV000144954.10","SCV000144954.11","SCV000144954.12","SCV000144954.13","SCV000144954.14","SCV000144954.15","SCV000144954.16","SCV000144954.17","SCV000144954.18","SCV000144954.19","SCV000144954.20","SCV000144954.21","SCV000144954.22","SCV000144954.23","SCV000144954.24","SCV000144954.25"],"id":"SCV000144954","local_key":"U14680.1:n.4184_4187delTCAA|MedGen:C2676676","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"504196"}
{"title":"NM_007294.3:c.4065_4068delTCAA AND Breast-ovarian cancer, familial 1","submission_id":"500037.2015-12-29","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000053742","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","date_created":"2012-11-07","version":"6","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2013-03-21","assertion_type":"variation to disease","internal_id":"89357","clinical_assertion_observation_ids":["SCV000053742.0"],"id":"SCV000053742","local_key":"SCRP_var_186","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"500037"}
{"submission_id":"504863.2016-06-09","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant allele predicted to encode a truncated non-functional protein.\"}"],"clinical_assertion_trait_set_id":"SCV000282322","review_status":"reviewed by expert panel","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"ENIGMA BRCA1/2 Classification Criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/hxnfuuxx/enigma_rules_2015-03-26.pdf\"}}},\"StudyDescription\":{\"$\":\"ENIGMA (Evidence-based Network for the Interpretation of Germline Mutant Alleles) is a consortium focused on determining the clinical significance of variants in BRCA1, BRCA2 and other known/suspected breast cancer genes. http://enigmaconsortium.org/\"}}","date_created":"2016-06-24","version":"1","trait_set_id":"1917","submission_names":["ENIGMA_2015-08-17"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-04-22","assertion_type":"variation to disease","internal_id":"537053","clinical_assertion_observation_ids":["SCV000282322.0"],"id":"SCV000282322","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"504863"}
{"submission_id":"26957.2019-01-29","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"This deletion of four nucleotides in BRCA1 is denoted c.4065_4068delTCAA at the cDNA level and p.Asn1355LysfsX10 (N1355KfsX10) at the protein level. The normal sequence, with the bases that are deleted in brackets, is ATAA[delTCAA]GAAG. The deletion causes a frameshift, which changes an Asparagine to a Lysine at codon 1355, and creates a premature stop codon at position 10 of the new reading frame. This variant is predicted to cause loss of normal protein function through either protein truncation or nonsense-mediated mRNA decay. This variant, also reported as BRCA1 4184del4 or 4184_4187delTCAA using alternate nomenclature, has been reported in association with hereditary breast cancer and in multiple individuals with breast, ovarian, or prostate cancer (Friedman 1994, Neuhausen 1996, Liede 2002, Meindl 2002, Farooq 2011, Couch 2015, Bu 2016, Chan 2018). We consider this variant to be pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000210049","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"GeneDx Variant Classification (06012015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/7oynscmk/mdi-5616_26957_genedx_interprules_final_061215.pdf\"}}}}","date_created":"2015-02-19","version":"13","trait_set_id":"9460","submission_names":["SUB5098196"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-12-19","assertion_type":"variation to disease","internal_id":"375724","clinical_assertion_observation_ids":["SCV000210049.0"],"id":"SCV000210049","local_key":"GDX:7571|Not Provided","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000159924","record_status":"current","submitter_id":"26957"}
{"submission_id":"500110.2020-03-06","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"The variant results in a shift of the reading frame, and is therefore predicted to result in the loss of a functional protein. Found in at least one symptomatic patient, and found in general population data that is consistent with pathogenicity.\"}"],"clinical_assertion_trait_set_id":"SCV000296305","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Quest Diagnostics Criteria\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"26467025\",\"@Source\":\"PubMed\"}}},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"26295337\",\"@Source\":\"PubMed\"}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23633455\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23519070\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20104584\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"7894493\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23175448\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29339979\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29752822\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28831036\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"25085752\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27553291\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29470806\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28724667\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21324516\",\"@Source\":\"PubMed\"}}]}}","date_created":"2016-07-29","version":"4","trait_set_id":"9460","submission_names":["SUB6975398"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-03-20","assertion_type":"variation to disease","internal_id":"573876","clinical_assertion_observation_ids":["SCV000296305.0"],"id":"SCV000296305","local_key":"2420169|not provided","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000159924","record_status":"current","submitter_id":"500110"}
{"submission_id":"505504.2016-07-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000296801","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2016-07-29","version":"1","trait_set_id":"9590","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2016-07-01","assertion_type":"variation to disease","internal_id":"574372","clinical_assertion_observation_ids":["SCV000296801.0"],"id":"SCV000296801","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN169374","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000238776","record_status":"current","submitter_id":"505504"}
{"submission_id":"1006.2017-02-23","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000540939","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"StudyDescription\":{\"$\":\"Variants for BRCA1/2 tests\"}}","date_created":"2017-04-13","version":"1","trait_set_id":"774","submission_names":["BRCA12"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-02-23","assertion_type":"variation to disease","internal_id":"1053858","clinical_assertion_observation_ids":["SCV000540939.0"],"id":"SCV000540939","local_key":"NM_007294.3:c.4065_4068delTCAA|Familial cancer of breast","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000476410","record_status":"current","submitter_id":"1006"}
{"submission_id":"505260.2017-04-17","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000564378","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-04-21","version":"1","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-11-20","assertion_type":"variation to disease","internal_id":"1099012","clinical_assertion_observation_ids":["SCV000564378.0"],"id":"SCV000564378","local_key":"NM_007294.3:c.4065_4068del|MedGen:C2676676","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505260"}
{"submission_id":"1050.2017-08-28","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000219238","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2015-03-28","version":"3","trait_set_id":"7920","submission_names":["CHEO20170828_update"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-02-01","assertion_type":"variation to disease","internal_id":"395994","clinical_assertion_observation_ids":["SCV000219238.0"],"id":"SCV000219238","local_key":"1776816|Orphanet:ORPHA145","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"1050"}
{"submission_id":"320494.2015-03-11","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000220878","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"Counsyl Autosomal Dominant Disease Classification criteria (2015)\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/soovr93u/mdi-5618_320494_counsyl_autosomal_dominant_disease_classification_criteria_(2015)_v1.pdf\"}}}],\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21559243\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23683081\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24549055\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23633455\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"17018160\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21324516\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"7894493\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"23175448\",\"@Source\":\"PubMed\"}}]}}","date_created":"2015-03-28","version":"1","trait_set_id":"1917","submission_names":["Counsyl_2015_03_01"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2014-11-14","assertion_type":"variation to disease","internal_id":"397634","clinical_assertion_observation_ids":["SCV000220878.0"],"id":"SCV000220878","local_key":"NM_007294.3(BRCA1):c.4065_4068delTCAA","interpretation_description":"Likely pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"320494"}
{"submission_id":"500035.2018-08-20","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000839242","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Mendelics Assertion Criteria 2017\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/chhjzatu/mendelics_assertion_criteria_2017.pdf\"}}}}","date_created":"2018-10-05","version":"1","trait_set_id":"7920","submission_names":["SUB4427121"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-07-02","assertion_type":"variation to disease","internal_id":"1611812","clinical_assertion_observation_ids":["SCV000839242.0"],"id":"SCV000839242","local_key":"NC_000017.10:g.41243480_41243483delTTGA|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"500035"}
{"title":"BRCA1, 4-BP DEL, 4185TCAA_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","submission_id":"3.2010-12-30","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000039531","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","date_created":"2011-01-25","version":"4","trait_set_id":"1917","submission_names":[],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"1994-12-01","assertion_type":"variation to disease","internal_id":"39531","clinical_assertion_observation_ids":["SCV000039531.0"],"id":"SCV000039531","local_key":"113705.0015_BREAST-OVARIAN CANCER, FAMILIAL, SUSCEPTIBILITY TO, 1","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"3"}
{"submission_id":"61756.2020-02-26","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Alterations resulting in premature truncation (e.g.reading frame shift, nonsense)\"}"],"clinical_assertion_trait_set_id":"SCV000186942","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"Ambry Autosomal Dominant and X-Linked criteria (3/2017)\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/nlauicnm/ad_xl_classificationscheme_03.2017_ambry.pdf\"}}},\"ClinVarSubmissionID\":{\"@localKeyIsSubmitted\":\"1\"},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"28831036\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24556621\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30825404\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"16455195\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29752822\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28724667\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29339979\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"29470806\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"24504028\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"28993434\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"27553291\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"30078507\",\"@Source\":\"PubMed\"}}]}}","date_created":"2014-08-01","version":"5","trait_set_id":"13598","submission_names":["NonExomeUpdate_101019AmbryReport"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2019-03-26","assertion_type":"variation to disease","internal_id":"305457","clinical_assertion_observation_ids":["SCV000186942.0"],"id":"SCV000186942","local_key":"a89762","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000131887","record_status":"current","submitter_id":"61756"}
{"submission_id":"505214.2017-03-15","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000577930","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-05-25","version":"1","trait_set_id":"1917","submission_names":["BRCA_Malaga"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-01-01","assertion_type":"variation to disease","internal_id":"1125848","clinical_assertion_observation_ids":["SCV000577930.0"],"id":"SCV000577930","local_key":"GNL0017|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505214"}
{"submission_id":"505849.2017-10-26","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000683147","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}}","date_created":"2018-02-15","version":"1","trait_set_id":"13598","submission_names":["SUB3163908"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-04-13","assertion_type":"variation to disease","internal_id":"1338690","clinical_assertion_observation_ids":["SCV000683147.0"],"id":"SCV000683147","local_key":"Db4KrQBSZeoE7-orUyypkQ9ffftxzNCEBpQllhdTwYY|MedGen:C0027672","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000131887","record_status":"current","submitter_id":"505849"}
{"submission_id":"500026.2018-01-25","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"Variant summary: The BRCA1 c.4065_4068delTCAA (p.Asn1355Lysfs) variant results in a premature termination codon, predicted to cause a truncated or absent BRCA1 protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been classified as pathogenic by our laboratory (e.g. c.4117G\u003eT, p.Glu1373X; c.4158_4162delCTCTC, p.Ser1387fs). This variant has been reported in numerous HBOC patients with positive family history (e.g. Langston 1996, Spitzer 2000, Evans 2004, Borg 2010). This variant is absent in 121322 control chromosomes, suggesting that it is not a common, benign variant. In addition, multiple clinical diagnostic laboratories/reputable databases classified this variant as pathogenic. Taken together, this variant is classified as pathogenic.\"}"],"clinical_assertion_trait_set_id":"SCV000699105","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"LabCorp Variant Classification Summary - May 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"LabCorp Variant Classification Summary - May 2015.docx\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/pttb9itm/labcorp_variant_classification_method_-_may_2015.pdf\"}}},\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"8531967\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"14757871\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"20104584\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"10699917\",\"@Source\":\"PubMed\"}},{\"ID\":{\"$\":\"21702907\",\"@Source\":\"PubMed\"}}]}}","date_created":"2018-03-15","version":"1","trait_set_id":"7920","submission_names":["2016-2017-variants"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-08-22","assertion_type":"variation to disease","internal_id":"1365457","clinical_assertion_observation_ids":["SCV000699105.0"],"id":"SCV000699105","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"500026"}
{"submission_id":"505954.2016-10-28","submitted_assembly":"hg18","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000325829","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"CIMBA Mutation Classification guidelines May 2016\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"CitationText\":{\"$\":\"CIMBA_Mutation_Classification_guidelines_May16.pdf\"},\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/MIHuUwlX/CIMBA_Mutation_Classification_guidelines_May16.pdf\"}}}}","date_created":"2016-11-04","version":"3","trait_set_id":"1917","submission_names":["CIMBA_20161005"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2015-10-02","assertion_type":"variation to disease","internal_id":"624937","clinical_assertion_observation_ids":["SCV000325829.0"],"id":"SCV000325829","local_key":"NM_007294.3:c.4065_4068del|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505954"}
{"submission_id":"506382.2018-04-04","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000733615","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","content":"{\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","date_created":"2018-04-06","version":"1","trait_set_id":"1917","submission_names":["SUB3868021"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"1414776","clinical_assertion_observation_ids":["SCV000733615.0"],"id":"SCV000733615","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"506382"}
{"title":"SUB2892902","submission_id":"505785.2017-07-24","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000584013","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":[{\"Attribute\":{\"$\":\"Autosomal dominant inheritance\",\"@Type\":\"ModeOfInheritance\"}},{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"@Type\":\"general\",\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}}],\"Citation\":[{\"@Type\":\"general\",\"ID\":{\"$\":\"11802209\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12402332\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"12698193\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9649133\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3405339\",\"@Source\":\"pmc\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"8571953\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"9150148\",\"@Source\":\"PubMed\"}},{\"@Type\":\"general\",\"ID\":{\"$\":\"3893336\",\"@Source\":\"pmc\"}}]}","date_created":"2017-07-26","version":"1","trait_set_id":"1917","submission_names":["SUB2892902"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-07-21","assertion_type":"variation to disease","internal_id":"1139118","clinical_assertion_observation_ids":["SCV000584013.0"],"id":"SCV000584013","local_key":"SUB2892902","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"505785"}
{"submission_id":"500086.2018-07-18","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000863590","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2018-12-20","version":"1","trait_set_id":"20192","submission_names":["SUB4310295"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2010-07-08","assertion_type":"variation to disease","internal_id":"1688796","clinical_assertion_observation_ids":["SCV000863590.0"],"id":"SCV000863590","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:CN221562","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000735453","record_status":"current","submitter_id":"500086"}
{"submission_id":"506247.2017-08-04","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000587372","review_status":"no assertion criteria provided","variation_archive_id":"VCV000017674","content":"{\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-04","version":"1","trait_set_id":"7920","submission_names":["RMGL-WCRI-05152017"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2014-01-31","assertion_type":"variation to disease","internal_id":"1140299","clinical_assertion_observation_ids":["SCV000587372.0"],"id":"SCV000587372","local_key":"286798|Orphanet:ORPHA145","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"506247"}
{"submission_id":"506497.2018-04-09","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000744620","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACGS Guidelines, 2013\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"URL\":{\"$\":\"https://submit.ncbi.nlm.nih.gov/ft/byid/3yyso7ro/evaluation_and_reporting_of_sequence_variants_bpgs_june_2013_-_finalpdf.pdf\"}}},\"StudyName\":{\"$\":\"VKGL Data-share Consensus\"}}","date_created":"2018-04-18","version":"1","trait_set_id":"1917","submission_names":["SUB3885264"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2017-05-31","assertion_type":"variation to disease","internal_id":"1451074","clinical_assertion_observation_ids":["SCV000744620.0"],"id":"SCV000744620","local_key":"NM_007294.3:c.4065_4068delTCAA|OMIM:604370","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000019243","record_status":"current","submitter_id":"506497"}
{"submission_id":"506152.2017-04-19","submitted_assembly":"GRCh37","interpretation_comments":[],"clinical_assertion_trait_set_id":"SCV000591484","review_status":"criteria provided, single submitter","variation_archive_id":"VCV000017674","content":"{\"AttributeSet\":{\"Attribute\":{\"$\":\"ACMG Guidelines, 2015\",\"@Type\":\"AssertionMethod\"},\"Citation\":{\"ID\":{\"$\":\"25741868\",\"@Source\":\"PubMed\"}}},\"StudyName\":{\"$\":\"The Canadian Open Genetics Repository (COGR)\"}}","date_created":"2017-08-25","version":"1","trait_set_id":"7920","submission_names":["SHS20170111"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"1147928","clinical_assertion_observation_ids":["SCV000591484.0"],"id":"SCV000591484","local_key":"NM_007294.3:c.4065_4068delTCAA|MedGen:C0677776","interpretation_description":"Pathogenic","variation_id":"17674","rcv_accession_id":"RCV000048431","record_status":"current","submitter_id":"506152"}
{"submission_id":"505789.2016-12-30","submitted_assembly":"GRCh37","interpretation_comments":["{\"text\":\"In this patient identified as compound heterozygous variants NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT].\"}"],"clinical_assertion_trait_set_id":"SCV000494066","review_status":"no assertion criteria provided","variation_archive_id":"VCV000424841","content":"{\"Interpretation\":{\"Citation\":{\"ID\":{\"$\":\"27884168\",\"@Source\":\"PubMed\"}}}}","date_created":"2017-01-26","version":"2","trait_set_id":"770","submission_names":["Ataxia_Telangiectasia"],"date_last_updated":"2020-03-26","assertion_type":"variation to disease","internal_id":"966237","clinical_assertion_observation_ids":["SCV000494066.0"],"id":"SCV000494066","local_key":"NM_000051.3:c.[497-1G\u003eA];[1236-2A\u003eT]|OMIM:208900","interpretation_description":"Uncertain significance","variation_id":"424841","rcv_accession_id":"RCV000416302","record_status":"current","submitter_id":"505789"}
{"submission_id":"506018.2018-05-10","submitted_assembly":"not applicable","interpretation_comments":["{\"text\":\"The p.V292M/R67H/R982C allele was found in trans with p.C634Y in a Chinese family, genotype c.[1901G\u003eA];[200G\u003eA;874G\u003eA;2944C\u003eT]. One family member had both variant RET alleles and MTC onset at 13 yrs. Family members with only the p.C634Y mutation had MEN2A. Family members with the p.V292M/R67H/R982C allele had MTC (70 yr) and C-cell hyperplasia (44 yr). Variants p.R67H and p.R982C are common and likely benign, GnomAD frequency 0.1% and 2%, respectively (gnomad.broadinstitute.org/gene/ENSG00000165731). For reports of p.V292M alone, see c.874G\u003eA.\"}"],"clinical_assertion_trait_set_id":"SCV000788260","review_status":"no assertion criteria provided","variation_archive_id":"VCV000549768","content":"{\"Interpretation\":{\"Citation\":[{\"ID\":{\"$\":\"21655256\",\"@Source\":\"PubMed\"}},{\"URL\":{\"$\":\"http://www.arup.utah.edu/database/MEN2/MEN2_display.php\"}}]}}","date_created":"2018-07-27","version":"1","trait_set_id":"8702","submission_names":["MEN2 update May 2018"],"date_last_updated":"2020-03-26","interpretation_date_last_evaluated":"2018-05-04","assertion_type":"variation to disease","internal_id":"1538355","clinical_assertion_observation_ids":["SCV000788260.0"],"id":"SCV000788260","local_key":"6|MedGen:CN073359","interpretation_description":"Pathogenic","variation_id":"549768","rcv_accession_id":"RCV000664336","record_status":"current","submitter_id":"506018"}
